Age-related differences in the clinical phenotypes of Behcet's disease: The experience of two referral centres

被引:2
作者
Tekgoz, Niluefer [1 ]
Tekgoz, Emre [2 ]
Colak, Seda [2 ]
Sezer, Muge [1 ]
Celikel, Elif [1 ]
Tekin, Zahide [1 ]
Cinar, Muhammet [2 ]
Yilmaz, Sedat [2 ]
Acar, Banu [1 ]
机构
[1] Univ Hlth Sci, Ankara City Hosp, Dept Pediat Rheumatol, Ankara, Turkiye
[2] Univ Hlth Sci Turkey, Gulhane Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkiye
关键词
Adult; age; Behcet's disease; paediatric; phenotype; CRITERIA;
D O I
10.1093/mr/road012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Behcet's disease (BD) is a multisystem disease and frequently occurs during the second-fourth decades of life, although disease onset may be seen at any age. This study aimed to analyze the influence of the age of onset on clinical manifestations of BD. Materials and methods This retrospective study analyzed two cohorts (paediatric and adult) to determine the association between the age of onset and clinical features in BD. Patients were classified into four groups to analyze the clinical characteristics according to the age of fulfilling the BD diagnostic criteria as follows: childhood onset (<12 years), adolescent onset (13-17 years), adult onset (18-39 years), and late onset (>40 years). Results The study included 801 patients with BD. Male predominance, pathergy test positivity, aphthosis (oral or genital), and skin and ocular involvements were higher among adult patients than paediatric patients. The presence of positive family history for BD, neuro-BD, and epididymitis were observed significantly common in the paediatric group. Conclusion There may be differences in clinical manifestations with regard to the age of disease onset. Disease presentations may differ from adult patients, and clinicians should be aware of the high familial aggregation rate of BD, especially in countries where the disease is endemic.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 25 条
[1]   Behcet Disease in Children [J].
Atmaca, Leyla ;
Boyvat, Ayse ;
Yalcindag, F. Nilufer ;
Atmaca-Sonmez, Pelin ;
Gurler, Aysel .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2011, 19 (02) :103-107
[2]   Characteristics of pediatric Behcet's disease in Turkey and Israel: A cross-sectional cohort comparison [J].
Aviel, Yonatan Butbul ;
Batu, Ezgi Deniz ;
Sozeri, Betul ;
Ayaz, Nuray Aktay ;
Baba, Lemor ;
Amarilyo, Gil ;
Simsek, Seval ;
Harel, Liora ;
Karadag, Serife Gul ;
Bilginer, Yelda ;
Ozen, Seza .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (03) :515-520
[3]  
Behcet H., 1940, Dermatologica, V81, P73, DOI [10.1159/000253787, DOI 10.1159/000253787]
[4]   Focus on neuro-Behcet's disease: A review [J].
Caruso, Paola ;
Moretti, Rita .
NEUROLOGY INDIA, 2018, 66 (06) :1619-1628
[5]   The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria [J].
Davatchi, F. ;
Assaad-Khalil, S. ;
Calamia, K. T. ;
Crook, J. E. ;
Sadeghi-Abdollahi, B. ;
Schirmer, M. ;
Tzellos, T. ;
Zouboulis, C. C. ;
Akhlagi, M. ;
Al-Dalaan, A. ;
Alekberova, Z. S. ;
Ali, A. A. ;
Altenburg, A. ;
Arromdee, E. ;
Baltaci, M. ;
Bastos, M. ;
Benamour, S. ;
Ben Ghorbel, I. ;
Boyvat, A. ;
Carvalho, L. ;
Chen, W. ;
Ben-Chetrit, E. ;
Chams-Davatchi, C. ;
Correia, J. A. ;
Crespo, J. ;
Dias, C. ;
Dong, Y. ;
Paixao-Duarte, F. ;
Elmuntaser, K. ;
Elonakov, A. V. ;
Grana Gil, J. ;
Haghdoost, A-A. ;
Hayani, R. M. ;
Houman, H. ;
Isayeva, A. R. ;
Jamshidi, A. R. ;
Kaklamanis, P. ;
Kumar, A. ;
Kyrgidis, A. ;
Madanat, W. ;
Nadji, A. ;
Namba, K. ;
Ohno, S. ;
Olivieri, I. ;
Vaz Patto, J. ;
Pipitone, N. ;
de Queiroz, M. V. ;
Ramos, F. ;
Resende, C. ;
Rosa, C. M. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (03) :338-347
[6]   Behcet's disease: epidemiology, clinical manifestations, and diagnosis [J].
Davatchi, Fereydoun ;
Chams-Davatchi, Cheyda ;
Shams, Hormoz ;
Shahram, Farhad ;
Nadji, Abdolhadi ;
Akhlaghi, Massoomeh ;
Faezi, Tahreh ;
Ghodsi, Zahra ;
Abdollahi, Bahar Sadeghi ;
Ashofteh, Farimah ;
Mohtasham, Negin ;
Kavosi, Hoda ;
Masoumi, Mariam .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (01) :57-65
[7]  
Demir S, 2019, CLIN EXP RHEUMATOL, V37, P147
[8]  
Gallizzi R., 2017, PEDIATR RHEUMATOL, V15, P1
[9]  
Gezgin Yildirim Deniz, 2020, Clin Exp Rheumatol, V38 Suppl 127, P105
[10]  
Hamzaoui Amira, 2014, Acta Med Iran, V52, P748